نتایج جستجو برای: emulsion vaccine

تعداد نتایج: 120149  

Journal: :iranian journal of microbiology 0
sujeet kumar kakdwip research centre, central institute of brackishwater aquaculture, kakdwip, 24 pgs (s), west bengal, india. vinodkumar chaturvedi bp division, indian veterinary research institute, bareilly, india. bablu kumar bp division, indian veterinary research institute, bareilly, india. pankaj kumar department of microbiology, bihar veterinary college, patna, india. sudharani somarajan post doctorate fellow, health center, university of texas, texas, usa. anilkumar mishra goat health division, central institute for research on goats, makdum, up, inida.

background and objectives : haemorrhagic septicaemia (hs), caused by pasteurella multocida, is the most important bacterial disease of cattle and buffaloes in india. oil adjuvant vaccine (oav) is the most potent vaccine available for the control of hs. the study aims to evaluate the effect of alum co-adjuvantation of oav on emulsion stability and immune response. materials and methods : two dif...

Journal: :Clinical and vaccine immunology : CVI 2007
Marc Mansour Robert G Brown Annette Morris Bruce Smith Scott A Halperin

The immunogenicities and efficacies of a licensed diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine and the same vaccine formulated in a liposome/oil emulsion adjuvant were compared in a mouse model of pertussis respiratory infection. A single dose of the liposome/oil emulsion-adjuvanted vaccine produced significantly higher antibody levels than one dose of the licens...

Journal: :The Onderstepoort journal of veterinary research 1987
C M Cameron B J Barnard E Erasmus W J Botha

A stable oil emulsion rabies vaccine with a low viscosity was composed by a formula previously employed for Newcastle disease vaccine. Cattle developed high and sustained antibody levels, and guinea pigs were found to be solidly immune after a single injection of this vaccine. Antibody responses in cattle to 2 oil emulsion ephemeral fever vaccines were not satisfactory after a single injection,...

Journal: :iranian journal of veterinary research 2006
m. moghaddam pour r. momayez m. a. akhavizadegan

an experimental inactivated oil-emulsion h9n2 avian influenza vaccine was formulated with 3 parts ofinactivated avian influenza antigen a/chicken/iran/101/1998(h9n2) emulsified in 7 parts of oil adjuvant.twelve week-old specific pathogen-free (spf) chickens were divided into seven groups of 10 birds. sixgroups were vaccinated with 1, 1/10th, 1/50th, 1/100th, 1/200th and 1/400th field dose of th...

Journal: :Revue scientifique et technique 1996
P Hunter

The performance of selected oil adjuvants containing Southern African Territories (SAT) serotypes of foot and mouth disease virus was assayed by testing antibody levels elicited in cattle, sheep and goats, and by testing protection of cattle on challenge. Various oil adjuvant formulations were tested initially in cattle and guinea pigs, and compared with a standard alhydrogel and saponin-based ...

2010
Jun-Gu Choi Youn-Jeong Lee Ji-Yeon Kim Yeon-Hee Kim Mi-Ra Paek Dong-Kun Yang Seong-Wan Son Jae-Hong Kim

In order to control the H9N2 subtype low pathogenic avian influenza (LPAI), an inactivated vaccine has been used in Korea since 2007. The Korean veterinary authority permitted the use of a single H9N2 LPAI vaccine strain to simplify the evolution of the circulating virus due to the immune pressure caused by the vaccine use. It is therefore important to determine the suitability of the vaccine s...

2015
Sujeet Kumar Vinod Kumar Chaturvedi Bablu Kumar Pankaj Kumar Sudha Rani Somarajan Anil Kumar Mishra Bhaskar Sharma

BACKGROUND AND OBJECTIVES Haemorrhagic septicaemia (HS), caused by Pasteurella multocida, is the most important bacterial disease of cattle and buffaloes in India. Oil adjuvant vaccine (OAV) is the most potent vaccine available for the control of HS. The study aims to evaluate the effect of alum co-adjuvantation of OAV on emulsion stability and immune response. MATERIALS AND METHODS Two diffe...

Journal: :Human Vaccines & Immunotherapeutics 2013

2014
Christopher H. Clegg Richard Roque Lucy A. Perrone Joseph A. Rininger Richard Bowen Steven G. Reed

The ongoing threat from Influenza necessitates the development of new vaccine and adjuvant technologies that can maximize vaccine immunogenicity, shorten production cycles, and increase global vaccine supply. Currently, the most successful adjuvants for Influenza vaccines are squalene-based oil-in-water emulsions. These adjuvants enhance seroprotective antibody titers to homologous and heterolo...

2016
Chung-Hsiung Huang Chiung-Yi Huang Chih-Ping Cheng Shih-Hsiung Dai Hsin-Wei Chen Chih-Hsiang Leng Pele Chong Shih-Jen Liu Ming-Hsi Huang

This study describes the feasibility and adjuvant mechanism of a degradable emulsion for tuning adaptive immune responses to a vaccine antigen. We featured a mouse model with ovalbumin (OVA) as the antigen to deepen our understanding of the properties of a degradable emulsion-based adjuvant, dubbed PELC, interacting with immune cells and to elucidate their roles in vaccine immunogenicity in viv...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید